CSMD1 and neoplasm: Thus, these inactivating CSMD1 mutations may possibly reveal their apparent phenotypic influence on tumor pathology only after mutations in critical gatekeeper genes produce a cell population in which the absence of normal CSMD1 creates a pathophysiological effect.